Skip to main content

Table 4 Summary statistics of quantitative variables in fundraising deals

From: Biopharma innovation trends during COVID-19 and beyond: an evidence from global partnerships and fundraising activities, 2011-2022

 

Category-level

Deal-level

 

Monthly Amount in 100 Million USD

Avg yearly Value in Million USD

 

coef/(std)

coef/(std)

Fed rate

-0.222**

-0.456*

 

(0.08)

(0.22)

Early

0.927***

0.457

 

(0.24)

(0.59)

Late

-1.412***

-1.964*

 

(0.29)

(0.80)

Discovery

0.111

-0.341

 

(0.17)

(0.35)

Early x Discovery

0.994***

2.428***

 

(0.25)

(0.62)

Late x Discovery

1.206***

1.655

 

(0.34)

(0.93)

Linear Time

0.002***

0.004***

 

(0.00)

(0.00)

Season (Q2)

-0.020

0.186

 

(0.13)

(0.35)

Season (Q3)

0.123

1.209***

 

(0.13)

(0.36)

Season (Q4)

-0.023

0.346

 

(0.13)

(0.35)

Constant

0.462

5.266***

 

(0.28)

(0.59)

sigma_u

  

Constant

1.350***

 
 

(0.18)

 

sigma_e

  

Constant

3.069***

 
 

(0.03)

 

R Squared

 

0.01

N of cases

4608

15302

  1. \(p<0.05\); **\(p<0.01\); ***\(p<0.001\)